Modeling the transition of lung cancer from early to advanced stage

ISSN： 0957-5243

Source： Cancer Causes and Control, Vol.20, Iss.9, 2009-11, pp. : 1559-1569

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Developments in stereotactic ablative radiotherapy for the treatment of early-stage lung cancer

By Westover Kenneth D Timmerman Robert

Lung Cancer Management, Vol. 2, Iss. 2, 2013-04 ,pp. : 129-139

Future Medicine

Access to resources Recommend Favorite

Docetaxel: As Neoadjuvant Therapy in Early-Stage or Locally Advanced Breast Cancer

By Wiseman Lynda R. Keam Susan J.

American Journal of Cancer, Vol. 5, Iss. 3, 2006-01 ,pp. : 199-206

Adis International

Access to resources Recommend Favorite

ASCO 2013: news in early-stage and advanced breast cancer

By Steger Günther G. Bartsch Rupert

memo - Magazine of European Medical Oncology, Vol. 6, Iss. 4, 2013-12 ,pp. : 227-232

Springer Publishing Company

Access to resources Recommend Favorite

Assessing quality of life following neoadjuvant therapy for early stage non-small cell lung cancer (NSCLC): results from a prospective analysis using the Lung Cancer Symptom Scale (LCSS)

By Gralla Richard

Supportive Care in Cancer, Vol. 17, Iss. 3, 2009-03 ,pp. : 307-313

Springer Publishing Company

Access to resources Recommend Favorite

Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab‐treated patients with advanced non–small cell lung cancer

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 13-20

John Wiley & Sons Inc

Access to resources Recommend Favorite